세계 바이오의약품 일회용 기술 시장 규모는 2024년 65억 달러에서 예측 기간 동안 11.6%의 연평균 복합 성장률(CAGR)로 성장하여 2029년 말 112억 달러 규모로 성장할 것으로 예상됩니다.
북미 시장은 2024년 20억 달러에서 연평균 10.6% 성장하여 2029년에는 34억 달러로 성장할 것으로 예상됩니다. 아시아태평양 시장은 2024년 18억 달러에서 연평균 13.3% 성장하여 2029년에는 33억 달러로 성장할 것으로 예상됩니다. 로 예상됩니다.
세계 바이오의약품 일회용 기술 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
- 역사적 분석 : 일회용 기술 기반
- 일회용 기술에 사용되는 원재료
- 폴리아미드
- 폴리카보네이트
- 폴리에틸렌
- 폴리에테르술폰
- 폴리프로필렌
- 폴리테트라플루오로에틸렌
- 폴리염화비닐
- 셀룰로오스 아세테이트
- 에틸렌 초산비닐
- 일회용 기술과 기존의 재이용 가능한 기술
- 바이오로직스 프로세스 개발 경로와 일회용 기술 응용
- Upstream 처리
- 세포 채취 및 정제
- Downstream 처리
제3장 시장 역학
- 시장 역학 : 현황
- 시장 성장 촉진요인
- 제품 발매 증가
- 맞춤형 의료 수요 증가
- 시장이 해결해야 할 과제와 제약
- 엄격한 규제와 검증 요건
- 플라스틱 폐기물 처분
- 통합 과제
- 시장 기회
- 단클론항체 제조 채택 확대
- Downstream 공정에서의 일회용 시스템
제4장 신기술과 개발
- 실시간 운영 모니터링
- 바이오리액터 소형화
- 자동화 및 로봇 통합
- 통합 연속 바이오프로세스
제5장 시장 세분화 분석
- 세분화 내역
- 시장 분석 : 기술별
- 일회용 바이오리액터
- 혼합, 보관 및 충전 시스템
- 여과 시스템
- 제어 시스템
- 동결 융해 시스템
- 크로마토그래피 시스템
- 원심 펌프
- 아이솔레이터
- 시장 분석 : 컴포넌트별
- 바이오프로세스 컨테이너
- 샘플링 시스템
- 일회용 센서
- 전송 시스템
- 미디어 백
- 필터 카트리지
- 튜브
- 커넥터
- 기타 일회용 제품
- 시장 분석 : 용도별
- 단클론항체
- 백신
- 줄기세포 및 기타 세포치료
- 혈액제제
- 유전자 치료
- 재조합 단백질
- 폴리클로널 항체
- 시장 분석 : 최종사용자별
- 바이오의약품 기업 및 수탁 제조업체
- 연구기관 및 학술기관
- 병리 레버러토리
- 지역별 분석
- 시장 분석 : 지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제6장 경쟁 정보
제7장 바이오의약품 일회용 기술 시장에서의 지속가능성
- 바이오의약품 일회용 기술 산업에서의 지속가능성
- 환경, 사회, 거버넌스에 관한 데이터 이해
- 환경 퍼포먼스
- 사회적 퍼포먼스
- 거버넌스 퍼포먼스
- BCC의 결론
제8장 부록
- 조사 방법
- 출전
- 약어
- 기업 개요
- ABER INSTRUMENTS LTD.
- ADOLF KUHNER AG
- CELLEXUS
- CELLTAINER
- CORNING INC.
- DANAHER CORP.
- DISTEK INC.
- EPPENDORF SE
- GETINGE
- LONZA
- MERCK KGAA
- SARTORIUS AG
- THERMO FISHER SCIENTIFIC INC.
LSH
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
The North American market for single-use technologies for biopharmaceuticals is expected to grow from $2.0 billion in 2024 and is projected to reach $3.4 billion by the end of 2029, at a CAGR of 10.6% during the forecast period of 2024 to 2029.
The Asia-Pacific market for single-use technologies for biopharmaceuticals is expected to grow from $1.8 billion in 2024 and is projected to reach $3.3 billion by the end of 2029, at a CAGR of 13.3% during the forecast period of 2024 to 2029.
Report Scope
This report summarizes the single-use technologies market, including a market snapshot and company profiles of key players. It provides a comprehensive market breakdown with in-depth information regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges and opportunities for the market. It provides information on emerging technologies and developments in the industry. It analyzes critical market players' financials, product portfolios and recent activities.
BCC Research analyzed and made projections of each market and its applications, along with forecasts for the next five years. The report also features profiles of leading companies in the biopharmaceutical single-use technologies industry, including Sartorius AG, Danaher Corp, Merck KGaA and Thermo Fisher Scientific Inc.
The market is segmented by geographical region into North America, Europe, Asia-Pacific and the Rest of the World (RoW). Regional analysis is further broken down by country as:
- North America: The U.S., Canada and Mexico.
- Europe: Germany, the U.K., France, Italy, Spain and the Rest of Europe.
- Asia-Pacific: China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific.
Data for market estimates have been provided for 2021 and 2022 as the historical years, 2023 as the base year and forecast through 2029.
Report Includes
- 220 data tables and 59 additional tables
- An analysis of the global markets for single-use technologies for biopharmaceutical manufacturing
- Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the size and revenue prospects of the global market, along with a market share analysis by technology, single-use component, application, end user, and region/country
- A look at recent technical advances in different sole-use technologies and bioreactors and the extent of adoption by commercial customers and regulatory authorities
- Facts and figures pertaining to the market dynamics, technical advances, regulations, and the impact of region- and industry-specific macroeconomic variables
- A Porter's Five Forces model, and global supply chain and PESTLE analyses
- Patent activity and key patent grants/publications, along with an analysis of the impact of new developments in sole-use technologies and bioreactors for pharmaceuticals
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
- Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook
- Profiles of market leaders, including Danaher Corp, Thermo Fisher Scientific Inc., Sartorius AG and Merck KGaA.
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Insights
Chapter 2 Market Overview
- Historical Analysis: The Foundation for Single-Use Technology
- Raw Materials Used in Single-Use Technologies
- Polyamide
- Polycarbonate
- Polyethylene
- Polyethersulfone
- Polypropylene
- Polytetrafluoroethylene
- Polyvinyl Chloride
- Cellulose Acetate
- Ethylene Vinyl Acetate
- Single-Use Technology Versus Traditional Reusable Technology
- Biologics Process Development Pathway and Application of Single-Use Technologies
- Upstream Processing
- Cell Harvesting and Clarification
- Downstream Processing
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Increasing Product Launches
- Growing Demand for Personalized Medicine
- Market Challenges and Restraints
- Stringent Regulations and Validation Requirements
- Disposal of Plastic Waste
- Integration Challenges
- Market Opportunities
- Growing Adoption for Monoclonal Antibodies Manufacturing
- Single-Use Systems in Downstream Operations
Chapter 4 Emerging Technologies and Developments
- Introduction
- Real-Time Monitoring of Operations
- Miniaturization of Bioreactors
- Integration of Automation and Robotics
- Integrated Continuous Bioprocessing
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis by Technology
- Single-Use Bioreactors
- Mixing, Storage and Filling Systems
- Filtration Systems
- Control Systems
- Freeze and Thaw Systems
- Chromatography Systems
- Centrifugal Pumps
- Isolators
- Market Analysis by Component
- Bioprocess Containers
- Sampling Systems
- Single-Use Sensors
- Transfer Systems
- Media Bags
- Filter Cartridges
- Tubing
- Connectors
- Other Single-Use Products
- Market Analysis by Application
- Monoclonal Antibodies
- Vaccines
- Stem Cell and Other Cell Therapies
- Blood Derivatives
- Gene Therapy
- Recombinant Proteins
- Polyclonal Antibodies
- Market Analysis by End User
- Biopharmaceutical Companies and Contract Manufacturers
- Research Institutes and Academia
- Pathology Laboratories
- Geographic Breakdown
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Competitive Landscape
- Partnerships
- Acquisitions
- Facility Expansions
- Patent Analysis
Chapter 7 Sustainability in the Single-Use Technologies for Biopharmaceuticals Market
- Sustainability in the Biopharmaceutical Single-Use Technologies Industry
- Understanding Environmental, Social and Governance Data
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks from BCC Research
Chapter 8 Appendix
- Methodology
- Sources
- Abbreviations
- Company Profiles
- ABER INSTRUMENTS LTD.
- ADOLF KUHNER AG
- CELLEXUS
- CELLTAINER
- CORNING INC.
- DANAHER CORP.
- DISTEK INC.
- EPPENDORF SE
- GETINGE
- LONZA
- MERCK KGAA
- SARTORIUS AG
- THERMO FISHER SCIENTIFIC INC.
